Lantheus Holdings, Inc. (LNTH)
60.84
-1.43
(-2.30%)
USD |
NASDAQ |
Dec 09, 16:00
61.00
+0.16
(+0.26%)
After-Hours: 17:42
Lantheus Holdings EPS Diluted (Quarterly): 0.4104 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cytokinetics, Inc. | -2.552 |
| Integra LifeSciences Holdings Corp. | -0.0704 |
| Iovance Biotherapeutics, Inc. | -0.2507 |
| Tandem Diabetes Care, Inc. | -0.3128 |
| Day One Biopharmaceuticals, Inc. | -0.1908 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 27.77M |
| Revenue (Quarterly) | 384.01M |
| Total Expenses (Quarterly) | 356.24M |
| Enterprise Value | 4.367B |
| Gross Profit Margin (Quarterly) | 57.91% |
| Profit Margin (Quarterly) | 7.23% |
| Earnings Yield | 3.91% |
| Operating Earnings Yield | 8.09% |
| Normalized Earnings Yield | 5.830 |